Pharmaceuticals & Biotechnology Editor | 03/20/2013
Robert Bronstein, Director Supply Operations at Macrogenics, speaks to Pharma IQ about the lack of visibility in the last mile of the supply chain and suggests ways the industry can overcome this. He also looks ahead to changes in regulations and how that will affect the Clinical Supply Chain.
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
Pharmaceutical Launch Excellence Summit
2 - 3 December, 2025
UK
Register Now |
View Agenda |
Learn More